Company news
CanaQuest Medical Corporation news in 2021
CanaQuest Medical Corporation's news releases, calls and decks from 2021, newest first.
CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health
April 28, 2021
CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications
April 6, 2021
CanaQuest Medical Corp Honored With International CBD Life Science R & D Excellence Award 2020 by Global Health & Pharma
March 28, 2021
Fundamental Research Corp Initiates Coverage on CanaQuest (CANQF) with Buy Rating and US$0.78 Fair Value Estimate
March 22, 2021
CanaQuest signs medicinal cannabis education partnership with the canadian cannabis dispute resolution centre
March 11, 2021
CanaQuest signs Mentanine® and Mentabinol® production and distribution agreement with PurCann Pharma and SiliCycle Inc.
February 2, 2021
CanaQuest president interviewed by the wall street analyzer
January 19, 2021
Decks in 2021
- Investor Presentation (December 2021)
Investor deck · 19 slides · Dec 30, 2021
- Investor Presentation (September 2021)
Investor deck · 17 slides · Sep 1, 2021
- Investor Presentation (April 2021)
Investor deck · 21 slides · April 2021
- Investor Presentation (January 2021)
Investor deck · 19 slides · January 2021